299 related articles for article (PubMed ID: 21112201)
1. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD.
Wu L; Ma L; Nicholson LF; Black PN
Respir Med; 2011 Mar; 105(3):329-36. PubMed ID: 21112201
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts.
Chen SC; Guh JY; Hwang CC; Chiou SJ; Lin TD; Ko YM; Huang JS; Yang YL; Chuang LY
J Cell Biochem; 2010 Jan; 109(1):38-48. PubMed ID: 19885844
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
[TBL] [Abstract][Full Text] [Related]
4. AGE, RAGE, and ROS in diabetic nephropathy.
Tan AL; Forbes JM; Cooper ME
Semin Nephrol; 2007 Mar; 27(2):130-43. PubMed ID: 17418682
[TBL] [Abstract][Full Text] [Related]
5. Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis.
Maeda S; Matsui T; Takeuchi M; Yamagishi S
Diabetes Metab Res Rev; 2013 Jul; 29(5):406-12. PubMed ID: 23508966
[TBL] [Abstract][Full Text] [Related]
6. Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants.
Kovacic P; Somanathan R
J Recept Signal Transduct Res; 2011 Oct; 31(5):332-9. PubMed ID: 21929288
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products: sparking the development of diabetic vascular injury.
Goldin A; Beckman JA; Schmidt AM; Creager MA
Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
[TBL] [Abstract][Full Text] [Related]
8. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Biochem Biophys Res Commun; 2010 Jul; 398(2):326-30. PubMed ID: 20599709
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end-products and the kidney.
Busch M; Franke S; Rüster C; Wolf G
Eur J Clin Invest; 2010 Aug; 40(8):742-55. PubMed ID: 20649640
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products in the skin are enhanced in COPD.
Hoonhorst SJ; Lo Tam Loi AT; Hartman JE; Telenga ED; van den Berge M; Koenderman L; Lammers JW; Boezen HM; Postma DS; Ten Hacken NH
Metabolism; 2014 Sep; 63(9):1149-56. PubMed ID: 25034386
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells.
Guimarães EL; Empsen C; Geerts A; van Grunsven LA
J Hepatol; 2010 Mar; 52(3):389-97. PubMed ID: 20133001
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications.
Yan SF; Ramasamy R; Schmidt AM
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):285-93. PubMed ID: 18332897
[TBL] [Abstract][Full Text] [Related]
13. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Takeuchi M
Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
16. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.
Mruthinti S; Sood A; Humphrey CL; Swamy-Mruthinti S; Buccafusco JJ
Neuroscience; 2006 Oct; 142(2):463-73. PubMed ID: 16890367
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background.
Kalousová M; Zima T; Tesar V; Dusilová-Sulková S; Skrha J
Mutat Res; 2005 Nov; 579(1-2):37-46. PubMed ID: 16084533
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases.
Grillo MA; Colombatto S
Amino Acids; 2008 Jun; 35(1):29-36. PubMed ID: 18008028
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications.
Yamagishi S
Ther Apher Dial; 2009 Dec; 13(6):534-9. PubMed ID: 19954478
[TBL] [Abstract][Full Text] [Related]
20. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products.
Basta G; Lazzerini G; Del Turco S; Ratto GM; Schmidt AM; De Caterina R
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1401-7. PubMed ID: 15845907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
